Document:

Exhibit 4.4

 Exhibit 4.4 
 EXCHANGE AND REGISTRATION RIGHTS AGREEMENT 
 dated
as of October 16, 2009 
 between 
 Barrick Gold Corporation 
 Barrick (PD) Australia Finance Pty Ltd 

 and 
 Citigroup Global Markets Inc., 
 Deutsche Bank Securities Inc. and 
 UBS Securities LLC 
 as Initial Purchasers 

 This Exchange and Registration Rights Agreement (this “Agreement”) is made
and entered into as of October 16, 2009, between Barrick Gold Corporation, a corporation organized under the laws of the Province of Ontario (the “Company”), Barrick (PD) Australia Finance Pty Ltd, a corporation existing under
the laws of the Commonwealth of Australia (“BPDAF” and, collectively with the Company, the “Issuers”), and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., UBS Securities LLC, Barclays Capital Inc., BMO
Capital Markets Corp., BNP Paribas Securities Corp., CIBC World Markets Corp., HSBC Securities (USA) Inc., SG Americas Securities, LLC, Banc of America Securities LLC, Goldman, Sachs & Co., Mitsubishi UFJ Securities (USA), Inc., RBS
Securities Inc., Standard Chartered Bank, TD Securities (USA) LLC, Credit Suisse Securities (USA) LLC, J.P. Morgan Securities Inc., Morgan Stanley & Co. Incorporated, RBC Capital Markets Corporation, Scotia Capital (USA) Inc. and Brookfield
Financial Corp. (collectively, the “Initial Purchasers”), each of whom has respectively agreed to purchase (i) BPDAF’s 4.950% Notes due 2020 (the “2020 Notes”) and (ii) BPDAF’s 5.950% Notes due
2039 (the “2039 Notes” and together with the 2020 Notes, the “Notes”) which are fully and unconditionally guaranteed by the Company as guarantor (the “Guarantee”), pursuant to the Purchase Agreement
(as defined below). The Notes and the Guarantees attached thereto are herein collectively referred to as the “Securities.” 
 This Agreement is made pursuant to the Purchase Agreement, dated October 13, 2009 (the “Purchase Agreement”), among the Issuers and the Initial Purchasers (i) for the benefit of
the Initial Purchasers and (ii) for the benefit of the holders from time to time of Transfer Restricted Securities (as defined herein), including the Initial Purchasers. In order to induce the Initial Purchasers to purchase the Notes, the
Issuers have agreed to provide the registration rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to the obligations of the Initial Purchasers set forth in Section 1(i) of the Purchase Agreement.

 The parties hereby agree as follows: 
 1. Certain Definitions. For purposes of this Agreement, the following terms shall have the following respective meanings: 
 “Base Interest” shall mean the interest that would otherwise accrue on the Notes under the terms
thereof and the Indenture, without giving effect to the provisions of this Agreement. 
 The term
“broker-dealer” shall mean any broker or dealer registered with the Commission under the Exchange Act. 
 “Canadian Prospectus” means a prospectus of BPDAF filed and receipted under Ontario Securities Laws and included in an Exchange Registration Statement or a Shelf
Registration Statement under the MJDS (with such additions and deletions as are required or permitted under the MJDS). 

 “Closing Date” shall mean the date on which the
Securities are initially issued. 
 “Commission” shall mean the United States Securities
and Exchange Commission, or any other federal agency at the time administering the Exchange Act or the Securities Act, whichever is the relevant statute for the particular purpose. 
 “Effective Time,” in the case of (i) an Exchange Registration, shall mean the time and date as
of which the Commission declares the Exchange Registration Statement effective or as of which the Exchange Registration Statement otherwise becomes effective and (ii) a Shelf Registration, shall mean the time and date as of which the Commission
declares the Shelf Registration Statement effective or as of which the Shelf Registration Statement otherwise becomes effective. 
 “Electing Holder” shall mean any holder of Transfer Restricted Securities that has returned a completed and signed Notice and Questionnaire to the Company (or its
counsel) in accordance with Section 3(b)(ii) or 3(b)(iii) hereof. 
 “Exchange Act”
shall mean the United States Securities Exchange Act of 1934, as amended. 
 “Exchange
Offer” shall have the meaning assigned thereto in Section 2(a) hereof. 
 “Exchange
Registration” shall have the meaning assigned thereto in Section 3(a) hereof. 
 “Exchange Registration Statement” shall have the meaning assigned thereto in Section 2(a) hereof. 
 “Exchange Securities” shall have the meaning assigned thereto in Section 2(a) hereof. 
 The term “holder” shall mean the Initial Purchasers and other persons who acquire Transfer
Restricted Securities from time to time (including any successors or assigns), in each case for so long as such person owns any Transfer Restricted Securities; provided that for purposes of any obligation of the Issuer to give notice to any holders,
“holder” shall mean the record owner of Transfer Restricted Securities. 
  

 2 

 “Indenture” shall mean the Indenture dated as of
October 16, 2009 between the Issuers and The Bank of New York Mellon, as Trustee (the “Trustee”), as the same shall be amended from time to time. 
 “Initial Purchasers” shall have the meaning ascribed to such term in the first paragraph of this
Agreement. 
 “MJDS” means the U.S./Canada Multijurisdictional Disclosure
System adopted by the Commission and Canadian securities regulators. 
 “Notice and
Questionnaire” means a Notice of Registration Statement and Selling Securityholder Questionnaire substantially in the form of Exhibit A hereto. 
 “Ontario Securities Laws” shall mean the Securities Act (Ontario) and the rules, regulations
and national, multijurisdictional and local instruments and published policy statements applicable in the province of Ontario. 
 “OSC” means the Ontario Securities Commission. 
 The term “person” shall mean a corporation, association, partnership, organization, business, individual, government or political subdivision thereof or governmental agency.

 “Registration Default” shall have the meaning assigned thereto in Section 2(c)
hereof. 
 “Registration Expenses” shall have the meaning assigned thereto in
Section 4 hereof. 
 “Resale Period” shall have the meaning assigned thereto in
Section 2(a) hereof. 
 “Restricted Holder” shall mean (i) a holder that is an
affiliate of an Issuer within the meaning of Rule 405, (ii) a holder who acquires Exchange Securities outside the ordinary course of such holder’s business, (iii) a holder who has arrangements or understandings with any person to
participate in the Exchange Offer for the purpose of

  

 3 

 
distributing Exchange Securities and (iv) a holder that is a broker-dealer, but only with respect to Exchange Securities received by such broker-dealer pursuant to an Exchange Offer in
exchange for Transfer Restricted Securities acquired by the broker-dealer directly from the Issuer. 
 “Rule 144,” “Rule 405” and “Rule 415” shall mean, in each case, such rule promulgated under the Securities Act (or any successor provision), as the same shall be
amended from time to time. 
 “Securities Act” shall mean the United States Securities
Act of 1933, as amended. 
 “Shelf Registration” shall have the meaning assigned thereto
in Section 2(b) hereof. 
 “Shelf Registration Statement” shall have the meaning
assigned thereto in Section 2(b) hereof. 
 “Special Interest” shall have the
meaning assigned thereto in Section 2(c) hereof. 
 “Transfer Restricted
Securities” shall mean each Security until: 
 (1) the date on which such Security has been
exchanged by a person other than a broker-dealer for an Exchange Security in the Exchange Offer; 
 (2)
following the exchange by a broker-dealer in the Exchange Offer of a Security for an Exchange Security, the date on which such Exchange Security is sold to a purchaser who receives from such broker-dealer on or prior to the date of such sale a copy
of the prospectus contained in the Exchange Registration Statement; 
 (3) the date on which such Security has
been effectively registered under the Securities Act and disposed of in accordance with the Shelf Registration Statement; or 
 (4) such Security shall cease to be outstanding. 
 “Trust Indenture Act” shall mean the Trust Indenture Act of 1939, or any successor thereto, and the rules, regulations and forms promulgated thereunder, all as the same shall be amended from time to time. 

 

 4 

 Unless the context otherwise requires, any reference herein to a “Section” or
“clause” refers to a Section or clause, as the case may be, of this Agreement, and the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to
any particular Section or other subdivision. 
 2. Registration Under the Securities Act. 
 (a) Except as set forth in Section 2(b) below, the Issuers agree to file under the Securities Act on or prior to 90 days after the
Closing Date, a registration statement on Form F-4/F-9 (which shall include a Canadian Prospectus in the form of a base shelf prospectus contemplated by National Instrument 44-102 - Shelf Distributions (“National Instrument
44-102”) or a short form prospectus or other appropriate form, prepared and filed with the OSC) or other appropriate form of registration statement relating to an offer to exchange (such registration statement, the “Exchange
Registration Statement”, and such offer, the “Exchange Offer”) any and all of the Securities for a like aggregate principal amount of debt securities issued by BPDAF, and guaranteed by the Company, which debt securities and
guarantee are substantially identical to the Notes and Guarantee (and are entitled to the benefits of a trust indenture which is substantially identical to the Indenture or is the Indenture and which has been qualified under the Trust Indenture
Act), except that they have been registered pursuant to an effective registration statement under the Securities Act and do not contain provisions for the additional interest contemplated in Section 2(c) below (such new debt securities,
together with the guarantee, hereinafter called “Exchange Securities”). The Exchange Securities will be issued as evidence of the same continuing indebtedness of the Issuers and will not constitute the creation of new indebtedness.
The Issuers agree to use their respective commercially reasonable efforts to cause the Exchange Registration Statement to become effective under the Securities Act on or prior to 270 days after the Closing Date. Notwithstanding the foregoing, if the
Issuers are not then eligible to file the Exchange Registration Statement or the filing of an Exchange Registration Statement is prohibited by any applicable law or applicable interpretation of the staff of the Commission or the OSC, the Issuers
shall then, to the extent not prohibited by applicable law or applicable interpretation of the staff of the Commission or the OSC, prepare and file an Exchange Registration Statement on Form F-4 or another appropriate form permitting registration of
the Transfer Restricted Securities under the Securities Act and in accordance with the methods of distribution elected by the holders and set forth in the Exchange Registration Statement. The Issuers further agree to use their best efforts to
commence and complete the Exchange Offer on or prior to 60 business days after such registration statement has become effective, hold the Exchange Offer open for not less than 20 business days and exchange Exchange Securities for all Transfer
Restricted Securities that have been properly tendered and not withdrawn on or prior to the expiration of the Exchange Offer. The Exchange Offer will be deemed to have been “completed” only if the Exchange Securities received by holders
other than Restricted Holders in the Exchange Offer for Transfer Restricted Securities are, upon receipt, transferable by each such holder without restriction under the Securities Act and the Exchange Act and without material restrictions under blue
sky or securities laws of a substantial majority of the States of the United States. The Exchange Offer shall be deemed to have been completed upon the earlier to occur of (i) the Issuers having exchanged the Exchange Securities for all

  

 5 

 
outstanding Transfer Restricted Securities pursuant to the Exchange Offer and (ii) the Issuers having exchanged, pursuant to the Exchange Offer, Exchange Securities for all Transfer
Restricted Securities that have been properly tendered and not withdrawn before the expiration of the Exchange Offer, which shall be on a date that is not less than 20 business days following the commencement of the Exchange Offer. The Issuers agree
(x) to include in the Exchange Registration Statement a prospectus for use in any resales by any holder of Exchange Securities that is a broker-dealer that has acquired such Transfer Restricted Securities for its own account as a result of
market-making activities or other trading activities and not directly from the Company, and (y) to keep such Exchange Registration Statement effective for a period (the “Resale Period”) beginning when Exchange Securities are
first issued in the Exchange Offer and ending upon the earlier of the expiration of the 180th day after the Exchange Offer has been completed or such time as such broker-dealers no longer own any Transfer Restricted Securities, other than Transfer
Restricted Securities acquired from the Company. With respect to such Exchange Registration Statement, such holders shall have the benefit of the rights of indemnification and contribution set forth in Sections 6(a), (c), (d) and
(e) hereof. 
 (b) If (i) on or prior to the time the Exchange Offer is completed, existing Commission interpretations
are changed such that the debt securities received by holders other than Restricted Holders in the Exchange Offer for Transfer Restricted Securities are not or would not be, upon receipt, transferable by each such holder without restriction under
the Securities Act, (ii) the Exchange Offer has not been completed within the applicable time period set forth in section 2(a) hereof or (iii) the Exchange Offer is not available to any holder of the Securities in the United States, the
Issuers shall, in lieu of (or, in the case of clause (iii), in addition to) conducting the Exchange Offer contemplated by Section 2(a), use their commercially reasonable efforts to file with the Commission on or prior to 90 days after the time
such obligation to file arises, a “shelf” registration statement on Form F-3/F-9 (which shall include a Canadian Prospectus in the form of a base shelf prospectus contemplated by National Instrument 44-102, prepared and filed with the OSC)
or other appropriate form of registration statement providing for the registration of, and the sale on a continuous or delayed basis by the holders of, all of the Transfer Restricted Securities, pursuant to Rule 415 or any similar rule that may be
adopted by the Commission (such filing, the “Shelf Registration” and such registration statement, the “Shelf Registration Statement”). The Issuers agree to use their commercially reasonable efforts (x) to cause
the Shelf Registration Statement to become or be declared effective on or prior to 270 days after such obligation to file arises and to keep such Shelf Registration Statement continuously effective for a period ending on the earlier of the first
anniversary of the Effective Time or such time as there are no longer any Transfer Restricted Securities outstanding, provided, however, that no holder shall be entitled to be named as a selling securityholder in the Shelf Registration
Statement or to use the prospectus forming a part thereof for resales of Transfer Restricted Securities unless such holder is an Electing Holder, and (y) after the Effective Time of the Shelf Registration Statement, promptly upon the request of
any holder of Transfer Restricted Securities that is not then an Electing Holder, to take any action reasonably necessary to enable such holder to use the prospectus forming a part thereof for resales of Transfer Restricted Securities, including,
without limitation, any action necessary to identify such holder as a selling securityholder in the Shelf Registration Statement, provided, however, that nothing in this clause (y) shall relieve any such holder of the obligation
to return a completed and signed Notice and

  

 6 

 
Questionnaire to the Issuers in accordance with Section 3(b)(iii) hereof. The Issuers further agree to supplement or make amendments to the Shelf Registration Statement, as and when required
by the rules, regulations or instructions applicable to the registration form used by the Issuers for such Shelf Registration Statement or by the Securities Act or rules and regulations thereunder for shelf registration, and the Issuers agree to
furnish to each Electing Holder copies of any such supplement or amendment prior to its being used or promptly following its filing with the Commission. 
 (c) In the event that (i) the Issuers have not filed the Exchange Registration Statement or Shelf Registration Statement on or prior to the date on which such registration statement is required to be
filed pursuant to Section 2(a) or 2(b), respectively, or (ii) such Exchange Registration Statement or Shelf Registration Statement has not become effective or been declared effective by the Commission on or prior to the date on which such
registration statement is required to become or be declared effective pursuant to Section 2(a) or 2(b), respectively, or (iii) the Exchange Offer has not been completed within 60 business days after the initial effective date of the
Exchange Registration Statement relating to the Exchange Offer (if the Exchange Offer is then required to be made), or (iv) any Exchange Registration Statement or Shelf Registration Statement required by Section 2(a) or 2(b) hereof is
filed and declared effective but thereafter ceases to be effective or usable in connection with resales of Transfer Restricted Securities during the time periods specified herein, or (v) the Issuers require holders to refrain from disposing of
their Securities or Exchange Securities under the circumstances described in Section 3(g) and that suspension period exceeds 45 days in one instance or 90 days in the aggregate during any consecutive 12-month period (each such event referred to
in clauses (i) through (v), a “Registration Default” and each period during which a Registration Default has occurred and is continuing, a “Registration Default Period”), then, as liquidated damages for such
Registration Default, subject to the provisions of Section 8(b), special interest (“Special Interest”), in addition to the Base Interest, shall accrue at a per annum rate of 0.25% with respect to the first 90-day period
immediately following the occurrence of the first Registration Default. The amount of the Special Interest will increase by an additional per annum rate of 0.25% with respect to each subsequent 90 day Registration Default Period until all
Registration Defaults have been cured, up to a maximum per annum rate of 0.50% of Special Interest for all Registration Defaults. Following the cure of all Registration Defaults, the accrual of Special Interest will cease. The Issuers shall pay all
Special Interest, if any, in the manner and on the dates specified in the Indenture. 
 (d) The Issuers shall use their
commercially reasonable efforts to take all actions necessary or advisable to be taken by them to ensure that the transactions contemplated herein are effected as so contemplated. Such actions may include amending and supplementing the prospectus
and amending the Exchange Registration Statement or Shelf Registration Statement if required by the rules, regulations or instructions applicable to the registration form used by the Issuers for such Exchange Registration Statement or Shelf
Registration Statement. 
 (e) Any reference herein to a registration statement as of any time shall be deemed to include any
document incorporated, or deemed to be incorporated, therein by reference as of

  

 7 

 
such time and any reference herein to any post-effective amendment to a registration statement as of any time shall be deemed to include any document incorporated, or deemed to be incorporated,
therein by reference as of such time. 
 3. Registration Procedures. 
 If the Issuers file a registration statement pursuant to Section 2(a) or Section 2(b), the following provisions shall apply:

 (a) In connection with the Issuers’ obligations with respect to the registration of Exchange Securities as contemplated
by Section 2(a) (the “Exchange Registration”), if applicable, the Issuers shall, as soon as practicable (or as otherwise specified): 
 (i) prepare and file with the Commission on or prior to 90 days after the Closing Date, an Exchange Registration Statement on Form F-4/F-9 (which shall include a Canadian Prospectus in the form of a base
shelf prospectus contemplated by National Instrument 44-102 or short form prospectus or other available form, prepared and filed with the OSC) or other appropriate form of registration statement which may be utilized by the Issuers and which shall
permit the Exchange Offer and resales of Exchange Securities by broker-dealers that have not acquired Transfer Restricted Securities directly from the Issuers during the Resale Period to be effected as contemplated by Section 2(a), and use its
commercially reasonable efforts to cause such Exchange Registration Statement to become effective on or prior to 270 days after the Closing Date; 
 (ii) as soon as practicable prepare and file with the Commission such amendments and supplements to such Exchange Registration Statement and the prospectus (which shall include a Canadian Prospectus or
amendment or supplement thereto as part of the Exchange Registration Statement if filed on Form F-4/F-9 under the MJDS) included therein as may be necessary to effect and maintain the effectiveness of such Exchange Registration Statement for the
periods and purposes contemplated in Section 2(a) hereof and as may be required by the applicable rules and regulations of the Commission and the instructions applicable to the form of such Exchange Registration Statement, and promptly provide
each broker-dealer holding Exchange Securities not acquired directly from the Company with such number of copies of the prospectus included therein (as then amended or supplemented), in conformity in all material respects with the requirements of
the Securities Act and the rules and regulations of the Commission thereunder, as such broker-dealer reasonably may request prior to the expiration of the Resale Period, for use in connection with resales of Exchange Securities; 
 (iii) promptly notify each broker-dealer that has requested or, to the knowledge of the Issuers, received copies of the
prospectus included in such registration statement,

  

 8 

 
and confirm such advice in writing, (A) in cases where a broker-dealer has specifically requested such information, when such Exchange Registration Statement or the prospectus included
therein or any prospectus amendment or supplement or post-effective amendment has been filed, (B) with respect to such Exchange Registration Statement or any post-effective amendment, when the same has become effective, (C) in cases where
a broker-dealer has specifically requested such information, any request by the Commission or the OSC for amendments or supplements to such Exchange Registration Statement or prospectus or for additional information, (D) of the issuance by the
Commission of any stop order suspending the effectiveness of such Exchange Registration Statement or the initiation or threatening of any proceedings for that purpose, (E) if at any time the representations and warranties of the Issuers
contemplated by Section 5 cease to be true and correct in all material respects, (F) of the receipt by the Issuers of any notification with respect to the suspension of the qualification of the Exchange Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose, or (G) at any time during the Resale Period when a prospectus is required to be delivered under the Securities Act, that such Exchange Registration Statement,
prospectus, prospectus amendment or supplement or post-effective amendment does not conform in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission
thereunder or any applicable Ontario Securities Laws or contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the
circumstances then existing; 
 (iv) in the event that the Issuers would be required, pursuant to
Section 3(a)(iii)(G) above, to notify any broker-dealers holding Exchange Securities, without delay prepare and furnish to each such holder a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered
to purchasers of such Exchange Securities during the Resale Period, such prospectus shall conform in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the
Commission thereunder and the Ontario Securities Laws, if applicable, and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing; 
 (v) use their commercially reasonable efforts to
obtain the withdrawal of any order suspending the effectiveness of such Exchange Registration Statement or any post-effective amendment thereto at the earliest practicable date; 
 (vi) use their commercially reasonable efforts to (A) register or qualify (or obtain an exemption from such
registration or qualification) the Exchange Securities under the securities laws or blue sky laws of such jurisdictions in the United States as are contemplated by Section 2(a) no later than the commencement of the Exchange Offer, (B) keep
such registrations or qualifications (or the exemptions therefrom) in effect and

  

 9 

 
comply with such laws so as to permit the continuance of offers, sales and dealings therein in such jurisdictions until the expiration of the Resale Period and (C) take any and all other
actions as may be reasonably necessary or advisable to enable each broker-dealer holding Exchange Securities to consummate the disposition thereof in such jurisdictions; provided, however, that the Company shall not be required for any such purpose
to (1) qualify as a foreign corporation in any jurisdiction wherein it would not otherwise be required to qualify but for the requirements of this Section 3(a)(vi), (2) consent to general service of process in any such jurisdiction or
(3) make any changes to its certificate of incorporation or by-laws or any agreement between it and its shareholders; 
 (vii) obtain the consent or approval of each governmental agency or authority, whether federal, state, provincial or local, which may be required to effect the Exchange Registration, the Exchange Offer
and the offering and sale of Exchange Securities by broker-dealers during the Resale Period; 
 (viii) provide a
CUSIP number for all Exchange Securities, not later than the applicable Effective Time; and 
 (ix) comply with
all applicable rules and regulations of the Commission and make generally available to its securityholders as soon as practicable but no later than eighteen months after the effective date of such Exchange Registration Statement, an earning
statement of the Company and its subsidiaries complying with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder). 
 (b) In connection with the Issuers’ obligations with respect to the Shelf Registration, if applicable, the Issuers shall, as soon as practicable (or as otherwise specified): 
 (i) prepare and file with the Commission, within the time periods specified in Section 2(b), a Shelf Registration
Statement on Form F-3/F-9 (which shall include a Canadian Prospectus in the form of a base shelf prospectus contemplated by National Instrument 44-102, prepared and filed with the OSC) or other appropriate form of registration statement which may be
utilized by the Issuers and which shall register all of the Transfer Restricted Securities for resale by the holders thereof in accordance with such method or methods of disposition as may be specified by such of the holders as, from time to time,
may be Electing Holders and use its commercially reasonable efforts to cause such Shelf Registration Statement to become effective within the time periods specified in Section 2(b); 
 (ii) not less than 30 calendar days prior to the Effective Time of the Shelf Registration Statement, mail the Notice and
Questionnaire to the holders of Transfer

  

 10 

 
Restricted Securities; provided that no holder shall be entitled to be named as a selling securityholder in the Shelf Registration Statement as of the Effective Time, and no holder shall
be entitled to use the prospectus forming a part thereof for resales of Transfer Restricted Securities at any time, unless such holder has returned a completed and signed Notice and Questionnaire to the Issuers (or their counsel) by the deadline for
response set forth therein; and provided, further, that holders of Transfer Restricted Securities shall have at least 28 calendar days from the date on which the Notice and Questionnaire is first mailed to such holders to return a completed
and signed Notice and Questionnaire to the Company (or their counsel); 
 (iii) after the Effective Time of the
Shelf Registration Statement, upon the request of any holder of Transfer Restricted Securities that is not then an Electing Holder, promptly send a Notice and Questionnaire to such holder; provided that the Issuers shall not be required to
take any action to name such holder as a selling securityholder in the Shelf Registration Statement or to enable such holder to use the prospectus forming a part thereof for resales of Transfer Restricted Securities until 30 days after such holder
has returned a completed and signed Notice and Questionnaire to the Issuers (or their counsel); 
 (iv) as soon
as practicable prepare and file with the Commission and, if applicable, the OSC such amendments and supplements to such Shelf Registration Statement and the prospectus (which shall include a Canadian Prospectus as part of the Exchange Registration
Statement if filed on Form F-3/F-9 under the MJDS) included therein as may be necessary to effect and maintain the effectiveness of such Shelf Registration Statement for the period specified in Section 2(b) hereof and as may be required by the
applicable rules and regulations of the Commission and the OSC and the instructions applicable to the form of such Shelf Registration Statement, and furnish to the Electing Holders copies of any such supplement or amendment simultaneously with or
prior to its being used or filed with the Commission and the OSC; 
 (v) comply with the provisions of the
Securities Act and any applicable Ontario Securities Laws with respect to the disposition of all of the Transfer Restricted Securities covered by such Shelf Registration Statement in accordance with the intended methods of disposition by the
Electing Holders provided for in such Shelf Registration Statement; 
 (vi) provide (A) any Electing
Holders, (B) the underwriters (which term, for purposes of this Agreement, shall include a person deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act), if any, thereof, (C) any sales or placement
agent therefor, (D) counsel for any such underwriter or agent and (E) not more than one counsel for all the Electing Holders, the opportunity to review and provide comments in connection with the preparation of such Shelf Registration
Statement, each prospectus included therein or filed with the Commission or, if applicable, the OSC and each amendment or supplement thereto; 
  

 11 

 (vii) for a reasonable period prior to the filing of such Shelf Registration
Statement, and throughout the period specified in Section 2(b), make available during reasonable business hours at the Issuers’ principal places of business or such other reasonable place for inspection by the persons referred to in
Section 3(b)(vi) such financial and other information and books and records of the Issuers, and cause the officers, employees, counsel and independent chartered accountants of the Issuers to respond to such inquiries, as shall be reasonably
necessary, in the judgment of the respective counsel referred to in such Section, to conduct a reasonable investigation within the meaning of Section 11 of the Securities Act; provided, however, that each such party shall be required to
agree in writing to maintain in confidence and not to disclose to any other person any information or records reasonably designated by the Issuers as being confidential, until such time as (A) such information becomes a matter of public record
(whether by virtue of its inclusion in such Shelf Registration Statement or otherwise), or (B) such person shall be required to disclose such information pursuant to a subpoena or order of any court or other governmental agency or body having
jurisdiction over the matter (subject to the requirements of such order, and only after such person shall have given the Issuers prompt prior written notice of such requirement); 
 (viii) promptly notify each of the Electing Holders, any sales or placement agent therefor and any underwriter thereof
(which notification may be made through any managing underwriter that is a representative of such underwriter for such purpose) and confirm such advice in writing, (A) when such Shelf Registration Statement or the prospectus included therein or
any prospectus amendment or supplement or post-effective amendment has been filed with the Commission or the OSC, and, with respect to such Shelf Registration Statement or any post-effective amendment, when the same has become effective, (B) in
cases where an Electing Holder has specifically requested such information in writing, of any comments by the Commission and by the blue sky or securities commissioner or regulator of any state or province with respect thereto or any request by the
Commission for amendments or supplements to such Shelf Registration Statement or prospectus or for additional information, (C) of the issuance by the Commission of any stop order suspending the effectiveness of such Shelf Registration Statement
or the initiation or threatening of any proceedings for that purpose, (D) if at any time the representations and warranties of the Issuers contemplated by Section 3(b)(xvii) or Section 5 cease to be true and correct in all material
respects, (E) of the receipt by the Issuers of any notification with respect to the suspension of the qualification of the Transfer Restricted Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such
purpose, or (F) if at any time when a prospectus is required to be delivered under the Securities Act or Ontario Securities Laws, that such Shelf Registration Statement, prospectus, prospectus amendment or supplement or post-effective amendment
does not conform in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and

  

 12 

 
regulations of the Commission thereunder or any applicable Ontario Securities Laws or contains an untrue statement of a material fact or omits to state any material fact required to be stated
therein or necessary to make the statements therein not misleading in light of the circumstances then existing; 
 (ix) use its best efforts to obtain the withdrawal of (A) any order suspending the effectiveness of such Shelf Registration Statement or any post-effective amendment thereto at the earliest practicable date or (B) the suspension
of the qualification of the Transfer Restricted Securities for sale in any jurisdiction; 
 (x) if requested by
any managing underwriter or underwriters, any placement or sales agent or any Electing Holder, promptly incorporate in a prospectus supplement or post-effective amendment such information as is required by the applicable rules and regulations of the
Commission or, if applicable, the OSC and as such managing underwriter or underwriters, such agent or such Electing Holder specifies should be included therein relating to the terms of the sale of such Transfer Restricted Securities, including
information with respect to the principal amount of Transfer Restricted Securities being sold by such Electing Holder or agent or to any underwriters, the name and description of such Electing Holder, agent or underwriter, the offering price of such
Transfer Restricted Securities and any discount, commission or other compensation payable in respect thereof, the purchase price being paid therefor by such underwriters and with respect to any other terms of the offering of the Transfer Restricted
Securities to be sold by such Electing Holder or agent or to such underwriters; and make all required filings of such prospectus supplement or post-effective amendment promptly after notification of the matters to be incorporated in such prospectus
supplement or post-effective amendment; 
 (xi) furnish to each Electing Holder, each placement or sales agent,
if any, therefor, each underwriter, if any, thereof and the respective counsel referred to in Section 3(b)(vi) an executed copy (or, in the case of an Electing Holder, a conformed copy) of such Shelf Registration Statement, each such amendment
and supplement thereto (in each case including all exhibits thereto (in the case of an Electing Holder of Transfer Restricted Securities, upon request) and documents incorporated by reference therein) and such number of copies of such Shelf
Registration Statement (excluding exhibits thereto and documents incorporated by reference therein unless specifically so requested by such Electing Holder, agent or underwriter, as the case may be) and of the prospectus included in such Shelf
Registration Statement (including each preliminary prospectus and any summary prospectus), in conformity in all material respects with the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the
Commission thereunder and any applicable Ontario Securities Laws, and such other documents, as such Electing Holder, agent, if any, and underwriter, if any, may reasonably request in order to facilitate the offering and disposition of the Transfer
Restricted Securities owned by such Electing Holder, offered or sold by such agent or underwritten by such underwriter and to permit such Electing Holder, agent and

  

 13 

 
underwriter to satisfy the prospectus delivery requirements of the Securities Act and any applicable Ontario Securities Laws; and the Issuers hereby consent to the use of such prospectus
(including such preliminary and summary prospectus) and any amendment or supplement thereto by each such Electing Holder and by any such agent and underwriter, in each case in the form most recently provided to such person by the Issuers, in
connection with the offering and sale of the Transfer Restricted Securities covered by the prospectus (including such preliminary and summary prospectus) or any supplement or amendment thereto; 
 (xii) use their best efforts to (A) register or qualify (or obtain an exemption from such registration or
qualification) the Transfer Restricted Securities to be included in such Shelf Registration Statement under such securities laws or blue sky laws of such jurisdictions in the United States as any Electing Holder and each placement or sales agent, if
any, therefor and underwriter, if any, thereof shall reasonably request and ensure that any Transfer Restricted Securities can be offered in a private placement in the province of Ontario, Canada if any Electing Holders are resident in the province
of Ontario, Canada, (B) keep such registrations or qualifications (or the exemptions therefrom) in effect and comply with such laws so as to permit the continuance of offers, sales and dealings therein in such jurisdictions during the period
the Shelf Registration is required to remain effective under Section 2(b) above and for so long as may be necessary to enable any such Electing Holder, agent or underwriter to complete its distribution of Securities pursuant to such Shelf
Registration Statement and (C) take any and all other actions as may be reasonably necessary or advisable to enable each such Electing Holder, agent, if any, and underwriter, if any, to consummate the disposition in such jurisdictions of such
Transfer Restricted Securities; provided, however, that the Issuers shall not be required for any such purpose to (1) qualify as a foreign corporation in any jurisdiction wherein it would not otherwise be required to qualify but for the
requirements of this Section 3(b)(xii), (2) consent to general service of process in any such jurisdiction, or (3) make any changes to its constating documents or by-laws or any agreement between it and its shareholders; 

(xiii) use their best efforts to obtain the consent or approval of each governmental agency or authority, whether federal
or state, which may be required to effect the Shelf Registration or the offering or sale in connection therewith or to enable the selling holder or holders to offer, or to consummate the disposition of, their Transfer Restricted Securities in the
United States; 
 (xiv) unless any Transfer Restricted Securities shall be in book-entry only form, cooperate
with the Electing Holders and the managing underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Transfer Restricted Securities to be sold, which certificates, if so required by any securities exchange
upon which any Transfer Restricted Securities are listed, shall be penned, lithographed or engraved, or produced by any combination of such methods, on steel engraved borders, and which certificates shall not bear any restrictive legends (unless
such Transfer

  

 14 

 
Restricted Securities are held by Electing Holders resident in the province of Ontario, Canada); and, in the case of an underwritten offering, enable such Transfer Restricted Securities to be in
such denominations and registered in such names as the managing underwriters may request at least two business days prior to any sale of the Transfer Restricted Securities; 
 (xv) provide a CUSIP number for all Transfer Restricted Securities, not later than the applicable Effective Time;

 (xvi) enter into one or more underwriting agreements, engagement letters, agency agreements, “best
efforts” underwriting agreements or similar agreements, as appropriate, including customary provisions relating to indemnification and contribution, and take such other actions in connection therewith as any Electing Holders aggregating at
least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding shall request in order to expedite or facilitate the disposition of such Transfer Restricted Securities in the United States; provided that
the Issuers shall not be required to enter into any such agreement more than twice with respect to all of the Transfer Restricted Securities and may delay entering into any such agreement until the consummation of any underwritten public offering in
which the Issuers shall be engaged provided that such delay is reasonable; 
 (xvii) whether or not an agreement
of the type referred to in Section 3(b)(xvi) hereof is entered into and whether or not any portion of the offering contemplated by the Shelf Registration is an underwritten offering or is made through a placement or sales agent or any other
entity, (A) make such representations and warranties to the Electing Holders and the placement or sales agent, if any, therefor and the underwriters, if any, thereof in form, substance and scope as are customarily made in connection with an
offering of debt securities pursuant to any appropriate agreement or to a registration statement filed on the form applicable to the Shelf Registration; (B) obtain opinions of counsel to the Issuers in customary form and covering such matters,
of the type customarily covered by such an opinion as the managing underwriters, if any, or as any Electing Holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding may reasonably
request, addressed to such Electing Holder or Electing Holders and the placement or sales agent, if any, therefor and the underwriters, if any, thereof and dated the effective date of such Shelf Registration Statement (and if such Shelf Registration
Statement contemplates an underwritten offering of a part or all of the Transfer Restricted Securities, dated the date of the closing under the underwriting agreement relating thereto); (C) obtain a “cold comfort” letter or letters
from the independent chartered accountants of the Company addressed to the selling Electing Holders, the placement or sales agent, if any, therefor or the underwriters, if any, thereof, dated (i) the effective date of such Shelf Registration
Statement and (ii) the effective date of any prospectus supplement to the prospectus included in such Shelf Registration Statement or post-effective amendment to such Shelf Registration Statement which includes unaudited or audited financial
statements as of a date or for a period

  

 15 

 
subsequent to that of the latest such statements included in such prospectus (and, if such Shelf Registration Statement contemplates an underwritten offering pursuant to any prospectus supplement
to the prospectus included in such Shelf Registration Statement or post-effective amendment to such Shelf Registration Statement which includes unaudited or audited financial statements as of a date or for a period subsequent to that of the latest
such statements included in such prospectus, dated the date of the closing under the underwriting agreement relating thereto), such letter or letters to be in customary form and covering such matters of the type customarily covered by letters of
such type; (D) deliver such documents and certificates, including officers’ certificates, as may be reasonably requested by any Electing Holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities at
the time outstanding or the placement or sales agent, if any, therefor and the managing underwriters if any, thereof to evidence the accuracy of the representations and warranties made pursuant to clause (A) above or those contained in
Section 5(a) hereof and the compliance with or satisfaction of any agreements or conditions contained in the underwriting agreement or other agreement entered into by the Company; and (E) undertake such obligations relating to expense
reimbursement, indemnification and contribution as are provided in Section 6 hereof; 
 (xviii) notify in
writing each holder of Transfer Restricted Securities of any proposal by the Issuers to amend or waive any provision of this Agreement pursuant to Section 8(h) hereof and of any amendment or waiver effected pursuant thereto, each of which
notices shall contain the text of the amendment or waiver proposed or effected, as the case may be; 
 (xix) in
the event that any broker-dealer registered under the Exchange Act shall underwrite any Transfer Restricted Securities or participate as a member of an underwriting syndicate or selling group or “assist in the distribution” (within the
meaning of the Conduct Rules (the “Conduct Rules”) of the Financial Industry Regulatory Authority (“FINRA”) or any successor thereto, as amended from time to time) thereof, whether as a holder of such Transfer
Restricted Securities or as an underwriter, a placement or sales agent or a broker or dealer in respect thereof, or otherwise, assist such broker-dealer in complying with the requirements of such Conduct Rules, including by (A) if such Conduct
Rules shall so require, engaging a “qualified independent underwriter” (as defined in such Conduct Rules) to participate in the preparation of the Shelf Registration Statement relating to such Transfer Restricted Securities, to exercise
usual standards of due diligence in respect thereto and, if any portion of the offering contemplated by such Shelf Registration Statement is an underwritten offering or is made through a placement or sales agent, to recommend the yield of such
Transfer Restricted Securities, (B) indemnifying any such qualified independent underwriter to the extent of the indemnification of underwriters provided in Section 6 hereof (or to such other customary extent as may be requested by such
underwriter), and (C) providing such information to such broker-dealer as may be required in order for such broker-dealer to comply with the requirements of the Conduct Rules; and 
  

 16 

 (xx) comply with all applicable rules and regulations of the Commission, and
make generally available to its securityholders as soon as practicable but in any event not later than eighteen months after the effective date of such Shelf Registration Statement, an earning statement of the Company and its subsidiaries complying
with Section 11(a) of the Securities Act (including, at the option of the Company, Rule 158 thereunder). 
 (c) In the
event that the Issuers would be required, pursuant to Section 3(a)(iii)(G) or Section 3(b)(viii)(F) above, to notify each broker-dealer, the Electing Holders, the placement or sales agent, if any, therefor and the managing underwriters, if
any, thereof, the Issuers shall without delay prepare and furnish to each of the Electing Holders, to each placement or sales agent, if any, and to each such underwriter, if any, a reasonable number of copies of a prospectus supplemented or amended
so that, as thereafter delivered to purchasers of Transfer Restricted Securities, such prospectus shall conform in all material respects to the applicable requirements of the Securities Act and the Trust Indenture Act and the rules and regulations
of the Commission thereunder and any applicable Ontario Securities Laws and shall not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing. Each Electing Holder agrees that upon receipt of any notice from the Issuers pursuant to Section 3(a)(iii)(G) or Section 3(b)(viii)(F) hereof, such broker-dealer, Electing Holder,
underwriter or placement or sales agent shall forthwith discontinue the disposition of Transfer Restricted Securities pursuant to the Exchange Registration Statement or the Shelf Registration Statement applicable to such Transfer Restricted
Securities until such broker-dealer, Electing Holder, underwriter or placement or sales agent shall have received copies of such amended or supplemented prospectus and if so directed by the Company, such broker-dealer, Electing Holder, underwriter
or placement or sales agent shall destroy or deliver to the Issuers (at the Issuers’ expense) all copies, other than permanent file copies, then in such Electing Holder’s possession of the prospectus covering such Transfer Restricted
Securities at the time of receipt of such notice. 
 (d) In the event of a Shelf Registration, in addition to the information
required to be provided by each Electing Holder in its Notice Questionnaire, the Issuers may require such Electing Holder to furnish to the Issuers such additional information regarding such Electing Holder and such Electing Holder’s intended
method of distribution of Transfer Restricted Securities as may be required in the reasonable judgment of counsel for the Issuers in order to comply with the Securities Act. Each such Electing Holder agrees to notify the Issuers as promptly as
practicable of any inaccuracy or change in information previously furnished by such Electing Holder to the Issuers or of the occurrence of any event in either case as a result of which any prospectus relating to such Shelf Registration contains or
would contain an untrue statement of a material fact regarding such Electing Holder or such Electing Holder’s intended method of disposition of such Transfer Restricted Securities or omits to state any material fact regarding such Electing
Holder or such Electing Holder’s intended method of disposition of such Transfer Restricted Securities required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, and
promptly to furnish to the Issuers any additional information required to correct and update any previously furnished information or

  

 17 

 
required so that such prospectus shall not contain, with respect to such Electing Holder or the disposition of such Transfer Restricted Securities, an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing. 
 (e) As a condition to its participation in the Exchange Offer pursuant to the terms of this Agreement, each holder of Transfer Restricted Securities shall furnish, upon the request of the Issuers, prior
to the completion of the Exchange Offer, a written representation to the Issuers to the effect that (A) it is not an affiliate of the Issuers, (B) it is not engaged in, and does not intend to engage in, and has no arrangement or
understanding with any person to participate in, a distribution of the Exchange Securities to be issued in the Exchange Offer and (C) it is acquiring the Exchange Securities in its ordinary course of business, and such holder shall make such
other written representations as the Issuers may reasonably request in order to comply with applicable Ontario Securities Laws. As a condition to its participation in the Exchange Offer pursuant to the terms of this Agreement, each holder shall
acknowledge and agree that any broker-dealer and any such holder using the Exchange Offer to participate in a distribution of the securities to be acquired in the Exchange Offer (1) could not under Commission policy as in effect on the date of
this Agreement rely on the position of the Commission enunciated in Morgan Stanley and Co., Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation (available May 13, 1988), as interpreted in the Commission’s letter to
Shearman & Sterling dated July 2, 1993, and similar no-action letters and (2) must comply with the registration and prospectus delivery requirements of the Securities Act in connection with a secondary resale transaction and that
such a secondary resale transaction must be covered by an effective registration statement containing the selling security holder information required by Item 507 or 508, as applicable, of Regulation S-K if the resales are of Exchange
Securities obtained by such holder in exchange for Securities acquired by such holder directly from the Issuers. 
 (f) Until
the expiration of one year after the Closing Date, the Issuers will not, and will not permit any of their “affiliates” (as defined in Rule 144) to, resell any of the Securities that have been reacquired by any of them except pursuant to an
effective registration statement under the Securities Act. 
 (g) By its acquisition of Securities or Exchange Securities each
Electing Holder and each broker-dealer agrees that, upon the Issuers providing notice to such Electing Holder or broker-dealer or the underwriter or placement or sales agent, as the case may be, (x) of the happening of any event of the kind
described in clauses (C), (D) or (G) of Section 3(a)(iii) hereof or clauses (B), (C) or (F) of Section 3(b)(viii) hereof, or (y) that the Board of Directors of the Company has resolved that the Issuers have a bona
fide business purpose for doing so, then, upon providing such notice (which shall refer to this Section 3(g)), the Issuers may delay the filing or the effectiveness of the Exchange Registration Statement or the Shelf Registration Statement (if
not then filed or effective, as applicable) and shall not be required to maintain the effectiveness thereof or amend or supplement the Exchange Registration Statement or the Shelf Registration Statement, in all cases, for a period (a “Delay
Period”) expiring upon the earlier to occur of (i) in the case of the immediately preceding clause (x), receipt by such broker-dealer,

  

 18 

 
Electing Holder, underwriter or placement or sales agent of the copies of the supplemented or amended prospectus contemplated by Section 3(c) hereof or until it is advised in writing by the
Issuers pursuant to Section 3(c) hereof that the use of the applicable prospectus may be resumed, and has received copies of any amendments or supplements thereto or (ii) in the case of the immediately preceding clause (y), the date which
is the earlier of (A) the date on which such business purpose ceases to interfere with the Issuers’ obligations to file or maintain the effectiveness of such Exchange Registration Statement or the Shelf Registration Statement pursuant to
this Agreement or (B) 60 days after the Issuers notify the Electing Holders of such good faith determination. The period of effectiveness of the Exchange Registration Statement provided for in Section 2(a) above and the Shelf Registration
Statement provided for in Section 2(b) shall each be extended by a number of days equal to the number of days during any Delay Period. No Delay Period shall exceed 45 consecutive days, and there shall not be more than two Delay Periods during
any 12-month period. 
 4. Registration Expenses. 
 The Issuers agree to bear and to pay or cause to be paid promptly all expenses incident to the Issuers’ performance of or compliance with this Agreement, including (a) any and all Commission,
OSC and FINRA registration, filing and review fees and expenses including reasonable fees and disbursements of counsel for the placement or sales agent or underwriters in connection with such registration, filing and review, (b) all fees and
expenses in connection with the qualification of the Securities for offering and sale under the State securities and blue sky laws referred to in Section 3(b)(xii) hereof and determination of their eligibility for investment under the laws of
such jurisdictions as any managing underwriters or the Electing Holders may designate, including any reasonable fees and disbursements of counsel for the Electing Holders or underwriters in connection with such qualification and determination,
(c) all expenses relating to the preparation, printing, production, distribution and reproduction of each registration statement required to be filed hereunder, each prospectus included therein or prepared for distribution pursuant hereto, each
amendment or supplement to the foregoing, the expenses of preparing the Securities for delivery and the expenses of printing or producing any underwriting agreements, agreements among underwriters, selling agreements and blue sky or legal investment
memoranda and all other documents in connection with the offering, sale or delivery of Securities to be disposed of (including certificates representing the Securities), (d) messenger, telephone and delivery expenses relating to the offering,
sale or delivery of Securities and the preparation of documents referred in clause (c) above, (e) fees and expenses of the Trustee under the Indenture, any agent of the Trustee and any counsel for the Trustee and of any collateral agent,
security trustee or custodian, (f) internal expenses (including all salaries and expenses of the Company’s officers and employees performing legal or accounting duties), (g) fees, disbursements and expenses of counsel of the Issuers
and independent chartered accountants of the Company (including the expenses of any opinions or “cold comfort” letters required by or incident to such performance and compliance), (h) fees, disbursements and expenses of any
“qualified independent underwriter” engaged pursuant to Section 3(b)(xix) hereof, (i) reasonable fees, disbursements and expenses of one counsel for the Electing Holders retained in connection with a Shelf Registration, as
selected by the Electing Holders of at least a majority in aggregate

  

 19 

 
principal amount of the Transfer Restricted Securities held by Electing Holders (which counsel shall be reasonably satisfactory to the Company and which counsel may also be counsel for the
Initial Purchasers), (j) any fees charged by securities rating services for rating the Securities, and (k) fees, expenses and disbursements of any other persons, including special experts, retained by the Issuers in connection with such
registration (collectively, the “Registration Expenses”). To the extent that any Registration Expenses are incurred, assumed or paid by any holder of Transfer Restricted Securities or any placement or sales agent therefor or
underwriter thereof, the Issuers shall reimburse such person for the full amount of the Registration Expenses so incurred, assumed or paid promptly after receipt of a request therefor with supporting documentation evidencing the Registration
Expenses. Notwithstanding the foregoing, the holders of the Transfer Restricted Securities being registered shall pay all agency fees and commissions and underwriting discounts and commissions attributable to the sale of such Transfer Restricted
Securities and the fees and disbursements of any counsel or other advisors or experts retained by such holders (severally or jointly), other than the counsel and experts specifically referred to above. 
 5. Representations and Warranties. 
 The Company, as issuer and guarantor, and BPDAF, as issuer, represent and warrant to, and agree with, the Initial Purchasers and each of the holders from time to time of Transfer Restricted Securities that: 
 (a) Each registration statement covering Transfer Restricted Securities and each prospectus (including any preliminary or summary
prospectus) contained therein or furnished pursuant to Section 3(b) or Section 3(a) hereof and any further amendments or supplements to any such registration statement or prospectus, when it becomes effective or is filed with the OSC and
the Commission, as the case may be, and, in the case of an underwritten offering of Transfer Restricted Securities, at the time of the closing under the underwriting agreement relating thereto, will conform in all material respects to the
requirements of the Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any applicable Ontario Securities Laws and will not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein in the case of a registration statement, not misleading, and in the case of a prospectus not misleading in light of the circumstances under which they were made;
and at all times subsequent to the Effective Time when a prospectus would be required to be delivered under the Securities Act, other than from (i) such time as a notice has been given to holders of Transfer Restricted Securities pursuant to
Section 3(b)(viii)(F) or Section 3(a)(iii)(G) hereof until (ii) such time as the Issuers furnish an amended or supplemented prospectus pursuant to Section 3(c) or Section 3(a)(iv) hereof, each such registration statement,
and each prospectus (including any summary prospectus) contained therein or furnished pursuant to Section 3(b) or Section 3(a) hereof, as then amended or supplemented, will conform in all material respects to the requirements of the
Securities Act and the Trust Indenture Act and the rules and regulations of the Commission thereunder and any applicable Ontario Securities Laws and will not contain an untrue statement of a material fact or omit to state a material fact required to
be stated therein or

  

 20 

 
necessary to make the statements therein not misleading in the light of the circumstances then existing; provided, however, that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity with information furnished in writing to the Issuers by a holder of Transfer Restricted Securities or any underwriter or placement agent of any offering described therein expressly for
use therein. 
 (b) Any documents incorporated by reference in any prospectus referred to in Section 5(a) hereof, when they
become or became effective or are or were filed with the Commission and the OSC, as the case may be, will conform or conformed in all material respects to the requirements of the Securities Act, the Exchange Act or any applicable Ontario Securities
Laws, as applicable, and none of such documents will contain or contained, when filed, an untrue statement of a material fact or will omit or omitted, when filed, to state a material fact required to be stated therein or necessary to make the
statements therein not misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Issuers by a
holder of Transfer Restricted Securities or any underwriter or placement agent of any offering described therein expressly for use therein. 
 (c) The compliance by an Issuer with all of the provisions of this Agreement and the consummation of the transactions herein contemplated will not conflict with or result in a breach of any of the terms
or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which an Issuer or any subsidiary of an Issuer is a party or by which an Issuer or any subsidiary of an
Issuer is bound or to which any of the property or assets of an Issuer or any subsidiary of an Issuer is subject, nor will such action result in any violation of the provisions of the articles of incorporation or the by-laws or other organizational
documents, as applicable, of the Issuers or any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Issuers or any subsidiary of the Issuers or any of their properties and no consent,
approval, authorization, order, registration or qualification of or with any such court or governmental agency or body is required for the consummation by the Issuers of the transactions contemplated by this Agreement, except the registration under
the Securities Act of the Transfer Restricted Securities and the Exchange Securities, qualification of the Indenture under the Trust Indenture Act and such consents, approvals, authorizations, registrations or qualifications as may be required under
any applicable Ontario Securities Laws, Canadian federal or provincial corporate law or State securities or blue sky laws in connection with the offering and distribution of the Transfer Restricted Securities and the Exchange Securities. 

(d) This Agreement has been duly authorized, executed and delivered by the Issuers. 
  

 21 

 6. Indemnification. 
 (a) Indemnification by the Issuers. The Issuers, jointly and severally, will indemnify and hold harmless each of the Initial Purchasers, the holders of Transfer Restricted Securities included in an
Exchange Registration Statement, each of the Electing Holders of Transfer Restricted Securities included in a Shelf Registration Statement and each person who participates as a placement or sales agent or as an underwriter in any offering or sale of
such Transfer Restricted Securities against any losses, claims, damages or liabilities, joint or several, to which such holder, agent or underwriter may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon: 
 (i) any information or statement contained in any
Exchange Registration Statement or Shelf Registration Statement, as the case may be, furnished by the Company to any such holder, Electing Holder, agent or underwriter, or any amendment or supplement thereto, as the case may be, under which such
Transfer Restricted Securities were registered under the Securities Act, which contains or is alleged to contain an untrue statement of a material fact or omits or is alleged to omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; or 
 (ii) any information or statement contained in any preliminary,
final or summary prospectus, as the case may be, furnished by the Company to any such holder, Electing Holder, agent or underwriter, or any amendment or supplement thereto, as the case may be, which at the time and in the light of the circumstances
under which it was made contains or is alleged to contain an untrue statement of a material fact or omits or is alleged to omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading,

 and will reimburse such holder, such Electing Holder, such agent and such underwriter for any legal or other expenses
reasonably incurred by them in connection with investigating or defending any such action, loss, claim, damage or liability as such expenses are incurred; provided, however, that the Issuers shall not be liable to any such person in any such
case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, or preliminary, final or summary
prospectus, or amendment or supplement thereto, in reliance upon and in conformity with written information furnished to the Issuers by such person expressly for use therein. 
 (b) Indemnification by the Holders and any Agents and Underwriters. The Issuers may require, as a condition to including any Transfer
Restricted Securities in any registration statement filed pursuant to Section 2(b) hereof and to entering into any underwriting agreement with respect thereto, that the Issuers shall have received an undertaking reasonably satisfactory to it
from the Electing Holder of such Transfer Restricted Securities and from each underwriter

  

 22 

 
named in any such underwriting agreement severally and not jointly, to (i) indemnify and hold harmless the Issuers and all other holders of Transfer Restricted Securities, against any
losses, claims, damages or liabilities to which the Issuers or such other holders of Transfer Restricted Securities may become subject, under the Securities Act, the Ontario Securities Laws or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in such registration statement, or any preliminary, final or summary prospectus contained therein
or furnished by the Issuers to any such Electing Holder, agent or underwriter, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with
written information furnished to the Issuers by such Electing Holder, agent or underwriter expressly for use therein, and (ii) reimburse the Issuers for any legal or other expenses reasonably incurred by the Issuers in connection with
investigating or defending any such action or claim as such expenses are incurred; provided, however, that no such Electing Holder shall be required to undertake liability to any person under this Section 6(b) for any amounts in excess
of the dollar amount of the proceeds to be received by such Electing Holder from the sale of such Electing Holder’s Transfer Restricted Securities pursuant to such registration. 
 (c) Notices of Claims, Etc. In case any proceeding (including any governmental investigation) shall be instituted involving any
person in respect of which indemnity may be sought pursuant to either Section 6(a) or 6(b) above, the indemnified party shall promptly notify the indemnifying party in writing and the indemnifying party, upon request of the indemnified party,
shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such
proceeding. In any such proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the
indemnified party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of
both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with
any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all indemnified parties and that all such fees and expenses shall be reimbursed
as they are incurred. The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party
agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending
or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified

  

 23 

 
party, unless such settlement (i) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding and (ii) does
not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of an indemnified party. 
 (d) Contribution. If for any reason the indemnification provisions contemplated by Section 6(a) or Section 6(b) are unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, claims,
damages or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages or liabilities (or actions
in respect thereof) in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities
(or actions in respect thereof), as well as any other relevant equitable considerations. The relative fault of such indemnifying party and indemnified party shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by such indemnifying party or by such indemnified party, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just and equitable if contributions pursuant to this Section 6(d) were determined by pro rata allocation (even if the
holders or any agents or underwriters or all of them were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to in this Section 6(d). The amount paid
or payable by an indemnified party as a result of the losses, claims, damages, or liabilities (or actions in respect thereof) referred to above shall be deemed to include any legal or other fees or expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 6(d), no holder shall be required to contribute any amount in excess of the amount by which the dollar amount of the
proceeds received by such holder from the sale of any Transfer Restricted Securities (after deducting any fees, discounts and commissions applicable thereto) exceeds the amount of any damages which such holder has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission, and no underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Transfer Restricted Securities
underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The holders’
and any underwriters’ obligations in this Section 6(d) to contribute shall be several in proportion to the principal amount of Transfer Restricted Securities registered or underwritten, as the case may be, by them and not joint.

 (e) The obligations of the Issuers under this Section 6 shall be in addition to any liability which the Issuers may
otherwise have and shall extend, upon the same terms and

  

 24 

 
conditions, to each officer, director and partner of each holder, agent and underwriter and each person, if any, who controls any holder, agent or underwriter within the meaning of the Securities
Act; and the obligations of the holders and any agents or underwriters contemplated by this Section 6 shall be in addition to any liability which the respective holder, agent or underwriter may otherwise have and shall extend, upon the same
terms and conditions, to each officer and director of any Issuer (including any person who, with his or her consent, is named in any registration statement as about to become a director of an Issuer) and to each person, if any, who controls an
Issuer within the meaning of the Securities Act. 
 7. Underwritten Offerings. 
 (a) Selection of Underwriters. If any of the Transfer Restricted Securities covered by the Shelf Registration are to be sold pursuant
to an underwritten offering, the managing underwriter or underwriters thereof shall be designated by Electing Holders holding at least a majority in aggregate principal amount of the Transfer Restricted Securities to be included in such offering,
provided that such designated managing underwriter or underwriters is or are reasonably acceptable to the Issuers. 
 (b)
Participation by Holders. Each holder of Transfer Restricted Securities hereby agrees with each other such holder that no such holder may participate in any underwritten offering hereunder unless such holder (i) agrees to sell such
holder’s Transfer Restricted Securities on the basis provided in any underwriting arrangements approved by the persons entitled hereunder to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney,
indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements. 
 8.
Miscellaneous. 
 (a) No Inconsistent Agreements. The Issuers represent, warrant, covenant and agree that they
have not granted, and shall not grant, registration rights with respect to Transfer Restricted Securities or any other securities which would be inconsistent with the terms contained in this Agreement. 
 (b) Specific Performance. The parties hereto acknowledge that there would be no adequate remedy at law if the Issuers fail to perform
any of their obligations hereunder and that the Initial Purchasers and the holders from time to time of the Transfer Restricted Securities may be irreparably harmed by any such failure, and accordingly agree that the Initial Purchasers and such
holders, in addition to any other remedy to which they may be entitled at law or in equity, shall be entitled to compel specific performance of the obligations of the Issuers under this Agreement in accordance with the terms and conditions of this
Agreement, in any court of the United States or any State thereof having jurisdiction. 
  

 25 

 (c) Notices. All notices, requests, claims, demands, waivers and other communications
hereunder shall be in writing and shall be deemed to have been duly given when delivered by hand, if delivered personally or by courier, or three days after being deposited in the mail (registered or certified mail, postage prepaid, return receipt
requested) as follows: If to the Issuers, to Barrick Gold Corporation, Brookfield Place, TD Canada Trust Tower, Suite 3700, 161 Bay Street, P.O. Box 212, Toronto, Ontario, Canada M5J 2S1, Attention: Vice President and Treasurer (with a copy to the
General Counsel), and if to a holder, to the address of such holder set forth in the security register or other records of the Issuers, or to such other address as the Issuers or any such holder may have furnished to the other in writing in
accordance herewith, except that notices of change of address shall be effective only upon receipt. 
 (d) Parties in
Interest. All the terms and provisions of this Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the parties hereto and the holders from time to time of the Transfer Restricted Securities and the
respective successors and assigns of the parties hereto and such holders. In the event that any transferee of any holder of Transfer Restricted Securities shall acquire Transfer Restricted Securities, in any manner, whether by gift, bequest,
purchase, operation of law or otherwise, such transferee shall, without any further writing or action of any kind, be deemed a beneficiary hereof for all purposes and such Transfer Restricted Securities shall be held subject to all of the terms of
this Agreement, and by taking and holding such Transfer Restricted Securities such transferee shall be entitled to receive the benefits of, and be conclusively deemed to have agreed to be bound by all of the applicable terms and provisions of this
Agreement. If the Issuers shall so request, any such successor, assign or transferee shall agree in writing to acquire and hold the Transfer Restricted Securities subject to all of the applicable terms hereof. 
 (e) Survival. The respective indemnities, agreements, representations, warranties and each other provision set forth in this
Agreement or made pursuant hereto shall remain in full force and effect regardless of any investigation (or statement as to the results thereof) made by or on behalf of any holder of Transfer Restricted Securities, any director, officer or partner
of such holder, any agent or underwriter or any director, officer or partner thereof, or any controlling person of any of the foregoing, and shall survive delivery of and payment for the Transfer Restricted Securities pursuant to the Purchase
Agreement and the transfer and registration of Transfer Restricted Securities by such holder and the consummation of an Exchange Offer. 
 (f) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
 (g) Headings. The descriptive headings of the several Sections and paragraphs of this Agreement are inserted for convenience only, do
not constitute a part of this Agreement and shall not affect in any way the meaning or interpretation of this Agreement. 
  

 26 

 (h) Entire Agreement; Amendments. This Agreement and the other writings referred to
herein (including the Indenture and the form of Securities) or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its subject matter. This Agreement supersedes all prior agreements and
understandings between the parties with respect to its subject matter. This Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or
prospectively) only by a written instrument duly executed by the Issuers and the holders of at least a majority in aggregate principal amount of the Transfer Restricted Securities at the time outstanding. Each holder of any Transfer Restricted
Securities at the time or thereafter outstanding shall be bound by any amendment or waiver effected pursuant to this Section 8(h), whether or not any notice, writing or marking indicating such amendment or waiver appears on such Transfer
Restricted Securities or is delivered to such holder. 
 (i) Inspection. For so long as this Agreement shall be in
effect, this Agreement and a complete list of the names and addresses of all the holders of Transfer Restricted Securities shall be made available for inspection and copying on any business day by any holder of Transfer Restricted Securities for
proper purposes only (which shall include any purpose related to the rights of the holders of Transfer Restricted Securities under the Securities, the Indenture and this Agreement) at the offices of the Company at the address thereof set forth in
Section 8(c) above and at the office of the Trustee under the Indenture. 
 (j) Counterparts. This Agreement may be
executed by the parties in counterparts, each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument. 
 (k) Service of Process. The Issuers (i) agree that any legal suit, action or proceeding against the Company brought by any
holder, the Initial Purchasers, agent or underwriter or by any person who controls any holder, agent or underwriter arising out of or based upon this Agreement or the transactions contemplated hereby may be instituted in any Federal or state court
located in the Borough of Manhattan in the City of New York in the State of New York (“New York Court”), (ii) waives, to the fullest extent each party may effectively do so, any objection which such party may now or hereafter
have to the laying of venue of any such proceeding and (iii) submits to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. The Company and BPDAF have each appointed CT Corporation Systems, 111 Eighth Avenue,
New York, New York 10011, as its authorized agent (the “Authorized Agent”) upon whom process may be served in any such legal suit, action or preceding against the Company arising out of or based on this Agreement or the transactions
contemplated hereby which may be instituted in any New York Court by any holder, agent or underwriter or by any person who controls any holder, agent or underwriter, expressly consents to the jurisdiction of any such court in respect of any such
action, and waives any other requirements of or objections to personal jurisdiction with respect thereto. Such appointments shall be irrevocable. The Company represents and warrants that the Authorized Agent has agreed to act as such agent for
service of process and agrees to take any and all action, including the filing of any and all documents and instruments, that may be necessary to continue such appointment in full force and

  

 27 

 
effect as aforesaid. Service of process upon the Authorized Agent and written notice of such service to the Company shall be deemed, in every respect, effective service of process upon the
Company. 
 (l) Judgment Currency. In respect of any judgment or order given or made for any amount due hereunder that is
expressed and paid in a currency (the “judgment currency”) other than United States dollars, the Issuers shall indemnify each holder, agent or underwriter against any loss incurred by such holder, agent or underwriter as a result of
any variation as between (i) the rate of exchange at which the United States dollar amount is converted into the judgment currency for the purpose of such judgment or order and (ii) the rate of exchange at which a holder, agent or
underwriter is able to purchase United States dollars with the amount of judgment currency actually received by such holder, agent or underwriter. The foregoing indemnity shall constitute a separate and independent obligation of the Issuers and
shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term “rate of exchange” shall include any premiums and costs of exchange payable in connection with the purchase of or conversion into
United States dollars. 
  

 28 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

			
	BARRICK GOLD CORPORATION
		
	By:	 	 /s/    Jamie C. Sokalsky

		 	Name: Jamie C. Sokalsky
		 	Title: Executive Vice President and Chief Financial Officer
		
	By:	 	 /s/    James W. Mavor

		 	Name: James W. Mavor
		 	Title: Vice President & Treasurer
	
	BARRICK (PD) AUSTRALIA FINANCE PTY LTD
		
	By:	 	 /s/    Jamie C. Sokalsky

		 	Name: Jamie C. Sokalsky
		 	Title:Director
		
	By:	 	 /s/    James W. Mavor

		 	Name: James W. Mavor
		 	Title: Director

  

 29 

 Confirmed and accepted as of the date first above written: 
  

			
	CITIGROUP GLOBAL MARKETS INC.
		
	By:	 	 /s/ Brian D. Bednarski

		 	Name: Brian D. Bednarski
		 	Title: Managing Director
	
	DEUTSCHE BANK SECURITIES INC.
		
	By:	 	 /s/ Richard Dalton

		 	Name: Richard Dalton
		 	Title: Director
		
	By:	 	 /s/ David Greenberg

		 	Name: David Greenberg
		 	Title: Managing Director
	
	UBS SECURITIES LLC
		
	By:	 	 /s/ Timothy J. C. Steele

		 	Name: Timothy J. C. Steele
		 	Title: Managing Director – Global Fixed Income Derivatives
		
	By:	 	 /s/ Christopher Fernando

		 	Name: Christopher Fernando
		 	Title: Associate Director – Debt Capital Markets

  

 30 

 Exhibit A 
 FORM OF INSTRUCTION TO DTC PARTICIPANTS  
 [Date of Mailing]

 URGENT — IMMEDIATE ATTENTION REQUESTED  
 DEADLINE FOR RESPONSE: [DATE]a 
 The Depository Trust Company (“DTC”) has identified you as a DTC Participant through which beneficial interests in the Barrick (PD) Australia Finance Pty Ltd (the “Company”) Notes due 20[20][39] (the
“Securities”) are held. 
 The Company is in the process of registering the Securities under the Securities Act of 1933 for
resale by the beneficial owners thereof. In order to have their Securities included in the registration statement, beneficial owners must complete and return the enclosed Notice of Registration Statement and Selling Securityholder Questionnaire.

 It is important that beneficial owners of the Securities receive a copy of the enclosed materials as soon as possible as their rights
to have the Securities included in the registration statement depend upon their returning the Notice and Questionnaire by [Deadline For Response]. Please forward a copy of the enclosed documents to each beneficial owner that holds interests
in the Securities through you. If you require more copies of the enclosed materials or have any questions pertaining to this matter, please contact Barrick Gold Corporation, Brookfield Place, TD Canada Trust Tower, Suite 3700, 161 Bay Street, P.O.
Box 212, Toronto, Ontario, Canada M5J 2S1, Attention:—. 
  

	a	 Not less than 28 calendar days from date of mailing 

 FORM OF NOTICE OF REGISTRATION STATEMENT 
 and 
 SELLING SECURITYHOLDER QUESTIONNAIRE 
 [Date] 
 Reference is hereby made to the Exchange and Registration Rights Agreement (the “Exchange and Registration Rights Agreement”) among Barrick
Gold Corporation (the “Company”) and Barrick (PD) Australia Finance Pty Ltd (“BPDAF”, and together with the Company (the “Issuers”), and the Initial Purchasers named therein. Pursuant to the
Exchange and Registration Rights Agreement, the Issuers have filed with the United States Securities and Exchange Commission (the “Commission”) a registration statement on Form F-3/F-9 or other appropriate form of registration
statement (the “Shelf Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the 4.950% Notes due 2020 of BPDAF and the 5.950%
Notes due 2039 of BPDAF, each as guaranteed by the Company (collectively, the “Securities”). A copy of the Exchange and Registration Rights Agreement is attached hereto. All capitalized terms not otherwise defined herein shall have
the meanings ascribed thereto in the Exchange and Registration Rights Agreement. 
 Each beneficial owner of Transfer Restricted Securities (as
defined below) is entitled to have the Transfer Restricted Securities beneficially owned by it included in the Shelf Registration Statement. In order to have Transfer Restricted Securities included in the Shelf Registration Statement, this Notice of
Registration Statement and Selling Securityholder Questionnaire (“Notice and Questionnaire”) must be completed, executed and delivered to the Company’s counsel at the address set forth herein for receipt ON OR BEFORE
[Deadline for Response]. Beneficial owners of Transfer Restricted Securities who do not complete, execute and return this Notice and Questionnaire by such date (i) will not be named as selling securityholders in the Shelf Registration
Statement and (ii) may not use the Prospectus forming a part thereof for resales of Transfer Restricted Securities. 
 Certain legal consequences arise from being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. Accordingly, holders and beneficial owners of Transfer Restricted Securities are advised to consult
their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Shelf Registration Statement and related Prospectus. 
 The term “Transfer Restricted Securities” is defined in the Exchange and Registration Rights Agreement. 
  

 2 

 ELECTION 
 The undersigned holder (the “Selling Securityholder”) of Transfer Restricted Securities hereby elects to include in the Shelf Registration Statement the Transfer Restricted Securities
beneficially owned by it and listed below in Item (3). The undersigned, by signing and returning this Notice and Questionnaire, agrees to be bound with respect to such Transfer Restricted Securities by the terms and conditions of this Notice and
Questionnaire and the Exchange and Registration Rights Agreement, including, without limitation, Section 6 of the Exchange and Registration Rights Agreement, as if the undersigned Selling Securityholder were an original party thereto.

 Upon any sale of Transfer Restricted Securities pursuant to the Shelf Registration Statement, the Selling Securityholder will be required to
deliver to the Company and Trustee the Notice of Transfer set forth in Appendix A to the Prospectus and as Exhibit B to the Exchange and Registration Rights Agreement. 
 The Selling Securityholder hereby provides the following information to the Company and represents and warrants that such information is accurate and complete: 
 QUESTIONNAIRE 
  

							
	(1)	 	(a)	 	Full Legal Name of Selling Securityholder:
		 		 	  

			
		 	(b)	 	Full Legal Name of Registered Holder (if not the same as in (a) above) of Transfer Restricted Securities Listed in Item (3) below:
		 		 	  

			
		 	(c)	 	Full Legal Name of DTC Participant (if applicable and if not the same as (b) above) Through Which Transfer Restricted Securities Listed in Item (3) below are
Held:
		 		 	  

  

											
	(2)	 		 	Address for Notices to Selling Securityholder:	  		  	
		 		 		  	  
	  		  	
		 		 		  	  
	  		  	
		 		 		  	  
	  		  	
		 		 	Telephone:	  	  
	  		  	
		 		 	Fax:	  	  
	  		  	
		 		 	Contact Person:	  	  
	  		  	
			
	(3)	 	Beneficial Ownership of Securities:	  	
		
		 	Except as set forth below in this Item (3), the undersigned does not beneficially own any Securities.

  

 3 

					
		 	(a)	 	Principal amount of Transfer Restricted Securities beneficially owned:
		 		 	  

			
		 		 	CUSIP No(s). of such Transfer Restricted Securities:
		 		 	  

			
		 	(b)	 	Principal amount of Securities other than Transfer Restricted Securities beneficially owned:
		 		 	  

			
		 		 	CUSIP No(s). of such other Securities:
		 		 	  

			
		 	(c)	 	Principal amount of Transfer Restricted Securities which the undersigned wishes to be included in the Shelf Registration Statement:
		 		 	  

			
		 		 	CUSIP No(s). of such Transfer Restricted Securities:
		 		 	  

		
	(4)	 	Beneficial Ownership of Other Securities of the Company:
		
		 	Except as set forth below, the undersigned Selling Securityholder is not the beneficial or registered owner of other securities of the Company, other than the
Securities listed above in Item (3).
		
		 	State any exceptions here:
		
	(5)	 	Relationships with the Company:
		
		 	Except as set forth below, neither the undersigned Selling Securityholder nor any of its affiliates, officers, directors or principal equity holders (5% or more) has
held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.
		
		 	State any exceptions here:
		
	(6)	 	Plan of Distribution:

 Except as set forth below, the undersigned Selling Securityholder intends to
distribute the Transfer Restricted Securities listed above in Item (3) only as follows (if at all): Such Transfer Restricted Securities may be sold from time to time directly by the undersigned 

  

 4 

 
Selling Securityholder or, alternatively, through underwriters, broker-dealers or agents. Such Transfer Restricted Securities may be sold in one or more transactions at fixed prices, at
prevailing market prices at the time of sale, at varying prices determined at the time of sale, or at negotiated prices. Such sales may be effected in transactions (which may involve crosses or block transactions) (i) on any national securities
exchange or quotation service on which the Registered Securities may be listed or quoted at the time of sale, (ii) in the over-the-counter market, (iii) in transactions otherwise than on such exchanges or services or in the
over-the-counter market, or (iv) through the writing of options. In connection with sales of the Transfer Restricted Securities or otherwise, the Selling Securityholder may enter into hedging transactions with broker-dealers, which may in turn
engage in short sales of the Transfer Restricted Securities in the course of hedging the positions they assume. The Selling Securityholder may also sell Transfer Restricted Securities short and deliver Transfer Restricted Securities to close out
such short positions, or loan or pledge Transfer Restricted Securities to broker-dealers that in turn may sell such securities. 
 State any exceptions here: 
 By signing below, the Selling Securityholder acknowledges that it understands its obligation to comply,
and agrees that it will comply, with the provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation M. 
 In the event that the Selling Securityholder transfers all or any portion of the Transfer Restricted Securities listed in Item (3) above after the date on which such information is provided to the Company, the Selling Securityholder
agrees to notify the transferee(s) at the time of the transfer of its rights and obligations under this Notice and Questionnaire and the Exchange and Registration Rights Agreement. 
 By signing below, the Selling Securityholder consents to the disclosure of the information contained herein in its answers to Items (1) through (6) above and the inclusion of such information in
the Shelf Registration Statement and related Prospectus. The Selling Securityholder understands that such information will be relied upon by the Company in connection with the preparation of the Shelf Registration Statement and related Prospectus.

 In accordance with the Selling Securityholder’s obligation under Section 3(b) of the Exchange and Registration Rights Agreement to
provide such information as may be required by law for inclusion in the Shelf Registration Statement, the Selling Securityholder agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein which may occur
subsequent to the date hereof at any time while the Shelf Registration Statement remains in effect. All notices hereunder and pursuant to the Exchange and Registration Rights Agreement shall be made in writing, by hand-delivery, first-class mail, or
air courier guaranteeing overnight delivery as follows: 
  

 5 

	 	(i)	To the Company: 

  
  
  
  
  
  
  
  
  

	 	(ii)	With a copy to: 

  
  
  
  
  
  
  
  
 Once this Notice and Questionnaire is executed by
the Selling Securityholder and received by the Company’s counsel, the terms of this Notice and Questionnaire, and the representations and warranties contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable
by the respective successors, heirs, personal representatives, and assigns of the Company and the Selling Securityholder (with respect to the Transfer Restricted Securities beneficially owned by such Selling Securityholder and listed in Item
(3) above). This Agreement shall be governed in all respects by the laws of the State of New York. 
  

 6 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Notice and Questionnaire to be
executed and delivered either in person or by its duly authorized agent. 
 Dated:
                             
  

			
	  

	 Selling Securityholder
 (Print/type full legal name of beneficial owner of Transfer Restricted Securities)

		
	By:	 	  

		 	Name:
		 	Title:

 PLEASE RETURN THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE FOR RECEIPT ON OR BEFORE
[DEADLINE FOR RESPONSE] TO THE COMPANY’S COUNSEL AT: 
  
  

 
  
  
  
  
  
  
  
  

 7 

 Exhibit B 
 FORM OF NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT 
 The Bank of New York 

Barrick (PD) Australia Finance Pty Ltd 
 c/o The
Bank of New York 
 101 Barclay Street, Floor 21W 
 New York, NY 10286 
 Attention: 
  

	 	Re:	Barrick (PD) Australia Finance Pty Ltd (the “Company”) Notes due 2039 

 Dear Sirs: 
 Please be advised that
                                        
has transferred $             aggregate principal amount of the above-referenced Notes pursuant to an effective Registration Statement on Form F-3/F-9 (File No.
333-            ) filed by the Company. 
 We hereby certify that the
prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied and that the above-named beneficial owner of the Notes is named as a “Selling Holder” in the Prospectus dated [—, 2009] or in supplements thereto, and that the aggregate principal amount of the Notes transferred are the Notes listed in such Prospectus opposite such owner’s name. 
 Dated: 
  

			
	Very truly yours,
	
	  

	(Name):
		
	By:	 	  

		 	(Authorized Signature)Offer of Employment to Richard J. Rodgers

 Exhibit 10.26 
 June 18, 2009 
 PERSONAL AND CONFIDENTIAL 
 Richard Rodgers 
  

					
	 	  		  	
			
	 	  		  	

  

	Re:	Offer of Employment 

 Dear Richard:

 It gives me great pleasure to offer you employment at Abraxis BioScience, LLC (the “Company”). I hope that you will find working at
the Company a richly rewarding experience. 
 The offer is as follows: 
  

	1.	Job Title/Location: Initially, your job title will be Senior Vice President, Finance & Administration; provided, that, within sixty (60) days after
the Effective Date, the board of directors of Abraxis BioScience, Inc. (“Parent”) may, in its discretion, appoint you as Senior Vice President and Chief Financial Officer of the Company and Parent. Your principal place of employment shall
be at the Company’s offices in Bridgewater, New Jersey. 

  

	2.	Start Date: June 22, 2009 (the “Effective Date”) 

  

	3.	Reporting To: Lonnie Moulder, President and Chief Executive Officer 

  

	4.	Salary: You will receive an annual base salary of $340,000.00. The Salary will be paid in accordance with the Company’s regularly established payroll
practice. The Salary hereof is a gross amount, and the Company will be required to withhold from such amount deductions with respect to Federal, state and local taxes, FICA, unemployment compensation taxes and similar taxes, assessments or
withholding requirements. 

  

	5.	Bonus Opportunity: The target bonus for this position is 45% of your Salary, subject to the terms and conditions of the Company’s bonus policy. You will be
eligible for the 2009 bonus plan (payable in 2010), which will be subject to equitable proration based on length of service. You will receive annual performance reviews starting in 2010. 

  

	6.	 Equity Compensation: Subject to approval of the Compensation Committee in its sole discretion, you will be granted an option to purchase 20,000
shares of common stock of Parent under Parent’s 2007 Stock Incentive Plan, which option shall (a) have an exercise price equal to the closing trading price of Parent’s common stock on the grant date, (b)

 Richard Rodgers 
 June 18, 2009 
  Page
 2
 
  

	 	 
vest in equal annual installments over a four-year period, starting on the first anniversary of the grant date, (c) vest in full upon the consummation of a Transaction (as defined below),
provided you are employed with the Company on the date of such Transaction, and (d) otherwise be evidenced by Parent’s standard form of stock option agreement. In addition, subject to approval of the Compensation Committee in its sole
discretion, you will be granted 15,000 restricted stock units under Parent’s 2007 Stock Incentive Plan, which restricted stock units shall (a) entitle you to one share of Parent’s common stock for each vested restricted stock unit,
(b) vest in equal annual installments over a four-year period, starting on the first anniversary of the grant date, (c) vest in full upon the consummation of a Transaction, provided you are employed with the Company on the date of such
Transaction, and (d) otherwise be evidenced by Parent’s standard form of restricted stock unit agreement. 

  

	7.	Sign-On Bonus: A sign-on bonus of $35,000, less all required withholdings and deductions, will be delivered to you within 30 days of the Effective Date,
subject to the successful completion of your pre-employment screening requirements. In the event you voluntarily terminate your employment with the Company (other than for Good Reason) or the Company terminates your employment for Cause, in each
case within one year of the Effective Date, you agree to repay to the Company the sign-on bonus within 30 days of your termination date. 

  

	8.	Severance: In the event that (i) the Company terminates your employment without Cause or (ii) you terminate your employment for Good Reason, in each
case prior to the consummation of a Transaction, then the Company shall pay you a single cash payment equal to eighteen (18) months of your then-current annual base salary plus an amount equal to your target bonus for the year in which the
termination occurs, prorated based on the number of days of employment during the year in which the termination has occurred, in each case less all applicable federal, state, and local withholdings and deductions. Such payment shall be made within
two and one-half (2.5) months following the date on which the termination occurs, subject to any required delay to satisfy the requirements of Section 409A as provided in Section 12. In addition, in the event of any such foregoing
termination of employment, the vesting of any stock options and other equity awards granted to you shall accelerate so that an additional twenty-five percent (25%) of the underlying shares shall vest on the termination date; provided, that no
more than 100% of the underlying shares subject to such options or other equity awards then-outstanding shall vest in the event the unvested portion on the termination date is less than twenty-five percent (25%). Your receipt of any payment or
other benefit under this paragraph shall be contingent upon your signing of a general release agreement satisfactory to the Company within the thirty (30) day period following your termination date and your non-revocation of such release
agreement during any statutorily-provided revocation period. If at any time you resign from or otherwise terminate your employment (other than for Good Reason) or you are terminated with Cause, you will not be eligible for any severance payment or
accelerated vesting of any equity. 

 Richard Rodgers 
 June 18, 2009 
  Page
 3
 
  

	9.	Relocation Assistance: To assist you and your immediate family with relocating to the New Jersey area, the Company will pay or reimburse you up to an aggregate
of $50,000 for (i) all reasonable moving costs, (ii) the reasonable costs for up to two exploratory trips to the New Jersey area, including airfare, lodging, meals, rental car and other incidental expenses, and (iii) reasonable
temporary housing in the New Jersey area for up to six (6) months; provided, that you must incur such costs on or before March 31, 2010 and must provide the Company with reasonably detailed backup documentation supporting the costs
incurred; provided, further, that the Company shall not be responsible for broker’s fees, real estate transfer taxes or any other costs associated with the relocation of you or your immediate family. In the event you voluntarily terminate your
employment with the Company (other than for Good Reason) or the Company terminates your employment for Cause, in each case within one year of the Effective Date, you agree to repay to the Company all relocation costs paid or reimbursed by the
Company within 30 days of your termination date. 

  

	10.	Transaction Bonus: Upon the consummation of a Transaction, provided that your employment has not terminated prior to the Transaction, you will be entitled to
receive a single cash payment equal to eighteen (18) months of your then-current annual base salary plus an amount equal to your target bonus for the year in which the Transaction occurs, prorated based on the number of days of employment prior
to the date of completion of the Transaction during the year in which the Transaction occurs, in each case less all applicable federal, state, and local withholdings and deductions. Such payment shall be made within two and one-half
(2.5) months following the date on which the Transaction occurs. 

  

	11.	 Definitions: For purposes of this letter, “Cause” shall mean any of the following: (a) a material breach of any agreement you
have with the Company, including, but not limited to, the Proprietary Interest Protection Agreement, or any policy of the Company, and such material breach is not cured to the reasonable satisfaction of the Company within twenty (20) days after
written notice to you; (b) conviction of a felony or any other crime involving dishonesty, breach of trust, moral turpitude, or physical harm to any person (including, but not limited to, the Company or any of its employees); (c) an act of
fraud, misconduct, or dishonesty in connection with the business of the Company; (d) failure to satisfactorily or adequately perform your duties hereunder as reasonably determined by the Company, including, but not limited to, your inability to
achieve goals, inability to work with others, insubordination or excessive tardiness, or failure to implement or follow a lawful policy or directive of the Company, and in each case such failure continues for a period of twenty (20) days after
written notice to you; (e) your receipt of a Final Written Warning for any reason; or (f) insobriety or other substance abuse during work activities. For purposes of this letter, “Good Reason” means, without your consent, the
occurrence of any of the following circumstances: (i) there is a change in your responsibilities which represents a material and adverse change from your overall responsibilities, taken as a whole (except any changes resulting from the proposed
corporate spin-off of Abraxis Health); or (ii) you are required to be based at any place outside a fifty (50) mile radius from Bridgewater, New Jersey, except for travel that is

 Richard Rodgers 
 June 18, 2009 
  Page
 4
 
  

	 	 
reasonably necessary in connection with the Company’s business. Your voluntary termination shall be deemed for purposes hereof to have occurred for Good Reason only if (i) you provide
written notice to the Company prior to resignation and within twenty (20) days after you become aware of the circumstances giving rise to Good Reason, (ii) the Company fails to correct the circumstances giving rise to Good Reason prior to
resignation and within thirty (30) days following receipt of such notice and (iii) you resign within fifteen (15) days following such thirty (30) day period. “Transaction” shall mean (i) a transaction (including,
but not limited to, a sale of equity interests, merger, consolidation, reorganization or recapitalization) pursuant to which the holders of the voting equity securities of the Company immediately prior to such transaction (or their affiliates) cease
to beneficially own more than fifty percent (50%) of voting equity securities of the Company or its successor (or, if there is a parent of the Company following such transaction, of the ultimate parent) immediately following such transaction,
(ii) a transaction (including, but not limited to, a merger, consolidation, reorganization or recapitalization) pursuant to which the holders of the voting capital stock of Parent immediately prior to such transaction (or their affiliates)
cease to beneficially own more than fifty percent (50%) of voting capital stock of Parent or its successor (or, if there is a parent of Parent following such transaction, of the ultimate parent) immediately following such transaction or
(iii) the Company sells all or substantially all of its assets to a third party; provided, that the proposed corporate spin-off of Abraxis Health shall not be considered a “Transaction” for purposes of this definition.

  

	12.	Section 409A: To the extent necessary to comply with Section 409A(a)(2)(B)(i) of the Internal Revenue Code of 1986, as amended (the “Code”)
(relating to payments made to certain “key employees” of certain publicly-traded companies), any severance payments payable to you under the terms of paragraph 8 which constitute deferred compensation subject to Code Section 409A to
which you would otherwise be entitled during the six (6) month period immediately following your separation from service will be paid on the earlier of (i) the first business day following the expiration of such six (6) month period
or (ii) your death. You and the Company shall reasonably cooperate with each other to avoid the imposition of any additional taxes, interest and/or penalty to you under Section 409A of the Code. 

  

	13.	Parachute Payment Excise Tax: 

 (a) Subject to paragraph 12(b), in the event that any payments or benefits (within the meaning of Section 280G(b)(2) of the Code) to you or for your benefit, paid or payable or distributed or distributable pursuant to the terms of this
offer letter or otherwise in connection with, or arising out of, your employment with the Company or a Transaction (a “Payment” or “Payments”) are deemed “parachute payments” (as that term is defined in
Section 280G(b)(2) of the Code, but determined without regard to Section 280G(b)(2)(A)(ii)) (the “Parachute Payments”), would be subject to the excise tax imposed by Code Section 4999, or any interest or penalties are
incurred by you with respect to such excise tax (such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the “Excise Tax”), then you will be entitled to

 Richard Rodgers 
 June 18, 2009 
  Page
 5
 
  

 
receive an additional payment (a “Gross-Up Payment”) in an amount such that after payment by you of all taxes (including any interest or penalties (other than interest and penalties
imposed by reason of your failure to file timely a tax return or pay taxes shown due on your return) imposed with respect to such taxes and the Excise Tax), including any Excise Tax imposed upon the Gross-Up Payment, you retain an amount of the
Gross-Up Payment equal to the Excise Tax imposed upon the Payments. 
 (b) Notwithstanding any other provision to the contrary,
in the event the total amount of Payments does not exceed 110% of the Capped Amount, no Gross-Up Payment shall be made, and instead the total amount of Payments shall be reduced or limited to the Capped Amount. The reduction of the amounts payable
hereunder, if applicable, shall be made by first reducing any cash payments. The “Capped Amount” means three (3) times your “base amount,” within the meaning of Section 280G(b)(3) of the Code, minus one dollar ($1).

 (c) You shall notify the Company in writing of the details of any claim by the Internal Revenue Service that, if successful,
would require the payment by the Company of the Gross-Up Payment or any additional Gross-Up Payment as soon as practicable, but no later than 10 business days after you are informed of such claim. You shall not pay such claim prior to the expiration
of the 30-day period following the date on which you give such notice to the Company (or such shorter period ending on the date that any payment of taxes with respect to such claim is due). If the Company notifies you prior to the expiration of such
period that the Company desires to contest such claim, you shall permit the Company to participate in any proceedings relating to such claim in such a manner as determined by the Company in its sole discretion, and fully cooperate with the Company
at the Company’s expense in good faith in order effectively to contest such claim in such manner as requested by the Company. 
 (d) As a result of the uncertainty in the application of Sections 4999 and 280G of the Code, it is possible that a Gross-Up Payment (or a portion thereof) will be paid which should not have been paid (an “Excess Payment”).

 (e) If an Excess Payment is determined by the applicable government authority to have been made, the amount of the Excess
Payment shall be promptly repaid by you to the Company. 
 (f) Notwithstanding anything contained in this offer letter to the
contrary, in the event that an Excise Tax will be imposed on any Payment or Payments, the Company shall pay to the applicable government taxing authorities, as Excise Tax withholding, the amount of the Excise Tax that the Company has actually
withheld from the Payment or Payments. 
 (g) Any Gross-Up Payment payable hereunder shall be made to you no later than the end
of the tax year following the tax year in which you remit payment of the applicable Excise Taxes to the applicable government taxing authority. 

 Richard Rodgers 
 June 18, 2009 
  Page
 6
 
  

	14.	Benefits: You will be entitled to participate in all benefit plans (including, but not limited to, any medical, dental, life insurance, retirement and disability
plans), which may be available from time to time to the employees of the Company. These benefits will generally take effect on the first day of the month following the Effective Date. Please see the enclosed materials for additional details. You
acknowledge and agree that the Company may, in its discretion, terminate at any time or modify from time to time any such benefit plans. 

  

	15.	Vacation: Vacation is accrued at a rate of four (4) weeks per year as described in our Employee Handbook. 

  

	16.	Pre-Employment Screening: This offer is contingent upon successful completion of a pre-employment drug screening and a background check.

  

	17.	Employment Verification: Prior to the Effective Date, you must present verification that you are eligible to be employed in the United States as required by law.
This can be accomplished by presenting your Social Security Card and driver’s license/state identification card. 

  

	18.	Prior Agreements: You represent that you have full authority to enter into this Agreement and you are not under any contractual restraint, which would prohibit
you from satisfactorily performing your duties to the Company under this Agreement. Prior to the Effective Date, you must submit to the Company any confidential or other employment agreements that you may have with your current employer.

  

	19.	Company Policies: You will be required to adhere to all Company policies and procedures as set forth in the Employee Handbook, the Code of Business Conduct and
as otherwise implemented from time to time. 

  

	20.	Confidentiality Agreement: Prior to the Effective Date, you must execute a Proprietary Interest Protection Agreement. 

  

	21.	Employment At Will: This offer is for EMPLOYMENT AT WILL such that your employment with the Company can be terminated by either you or the Company at any time,
for any reason, with or without prior notice. 

  

	22.	Arbitration. You agree that all disputes, controversies, and claims arising out of, relating to, or connected with this offer letter, or alleged breach thereof
or otherwise arising out of or related to this offer letter or your employment, shall be resolved exclusively through arbitration before a single arbitrator and administered by the American Arbitration Association in accordance with its
then-existing Employment Arbitration Rules. Such arbitration shall take place in New Jersey, or any other place selected by mutual agreement of the parties. All arbitration awards shall be final and binding upon the parties, and any judgment upon
such an award may be entered and enforced in any court of competent jurisdiction located in New Jersey or otherwise. 

 Richard Rodgers 
 June 18, 2009 
  Page
 7
 
  

	23.	Expiration of Offer: If this offer is not accepted by 5 pm (California time) on June 19, 2009, it will be considered automatically withdrawn and no longer
valid. 

 Please sign and date the enclosed copy of this letter and return it along with the new hire paperwork to me at Abraxis
BioScience, LLC, 11755 Wilshire Blvd., Suite 2000, Los Angeles, California 90025, no later than June 19, 2009. 
 I look forward to you
joining our organization. If you should have any questions, please contact me at 310.405.7460. 
  

	
	Sincerely,
	
	/s/ Katie Bava
	 Katie Bava
 Human Resources
Manager

  

	cc:	Personnel File 

 My signature indicates
acceptance of this offer: 
  

					
	/s/ Richard Rodgers	 		 	June 19, 2009
	Richard Rodgers	 		 	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]